Pfizer has named its head of oncology, Chris Boshoff, as its new research and development chief. The move is seen as part of a broader strategy, with some outlets suggesting the company is under pressure to change. Boshoff will take on a role that includes being the chief scientific officer, succeeding a predecessor whose name is not specified in the reports.